Literature DB >> 9058393

Prevalence and impact of migraine.

R B Lipton1, W F Stewart.   

Abstract

Knowledge of the epidemiology of migraine has expanded because of the recent proliferation of large scale population-based studies using standardized case definitions. Migraine is a highly prevalent disorder, affecting about 6% of men and 15% to 18% of women. Migraine prevalence is highest between the ages of 25 and 55 years, accounting for its enormous impact in the workplace. Migraine imposes a substantial burden on society as measured by direct and indirect costs. Because the indirect costs greatly exceed the direct costs and because migraine is underdiagnosed and undertreated, improvements in treatments in treatment should reduce individual suffering and reduce work loss in a cost-effective manner.

Entities:  

Mesh:

Year:  1997        PMID: 9058393     DOI: 10.1016/s0733-8619(05)70291-7

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  27 in total

Review 1.  Diagnosing migraine in the pediatric population.

Authors:  Paul Winner; Andrew D Hershey
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 2.  Chronic daily headaches in children.

Authors:  Andrew D Hershey; Marielle A Kabbouche; Scott W Powers
Journal:  Curr Pain Headache Rep       Date:  2006-10

Review 3.  Childhood periodic syndromes and migraine.

Authors:  Paul Winner
Journal:  Curr Pain Headache Rep       Date:  2005-06

4.  Chronic daily headache in the pediatric population.

Authors:  Andrew D Hershey; Jack Gladstein; Paul Winner
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

Review 5.  Genetics of menstrual migraine: the molecular evidence.

Authors:  Natalie Colson; Francesca Fernandez; Lyn Griffiths
Journal:  Curr Pain Headache Rep       Date:  2010-10

Review 6.  Insights and advances in post-traumatic headache: research considerations.

Authors:  Teshamae S Monteith; David Borsook
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

7.  The TNF-α-308G/A polymorphism is associated with migraine risk: A meta-analysis.

Authors:  Lian Gu; Yan Yan; Jianxiong Long; Li Su; Yanling Hu; Qing Chen; Juanjuan Xie; Guangliang Wu
Journal:  Exp Ther Med       Date:  2012-03-30       Impact factor: 2.447

Review 8.  Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.

Authors:  Paul L McCormack; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

9.  Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin.

Authors:  Fabiano C Tanuri; Eliângela de Lima; Mario F P Peres; Francisco R Cabral; Maria da Graça Naffah-Mazzacoratti; Esper Abrão Cavalheiro; José Cipolla-Neto; Eliova Zukerman; Débora Amado
Journal:  J Headache Pain       Date:  2009-01-27       Impact factor: 7.277

10.  Overview of Pediatric Headache.

Authors:  Paul Winner
Journal:  Curr Treat Options Neurol       Date:  2004-11       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.